Firm at a glance
Yukon Partners is a platform private equity firm headquartered in Minneapolis, MN, per its website [S1].
What they buy
Yukon Partners has assembled a portfolio spanning healthcare services, business services, consumer products, industrial, technology, and distribution sectors, according to its public portfolio page [S2]. Healthcare services represents the most concentrated area of activity, with approximately nine portfolio companies in the sector as of early 2025 [S2]. The firm’s investments range from urgent care and dental practices to food manufacturing, IT services, and aviation components, suggesting a generalist approach across middle-market platforms [S2].
Portfolio
Healthcare Services
American Eye Associates (2018), Behavioral Innovations (2024), ConvenientMD (2024), Fast Pace Health (2016), Golden State Dermatology (2015), HealthTrack (2015), Lumio Dental (2019), MD Alliance Solutions (2020), and Receivable Solutions (2019) [S2].
Business Services
Black Diamond Networks (2021), Liquid Tech Solutions (2025), Market Performance Group (2024), New Era Technology (2023), and Smart Care (2023) [S2].
Consumer Products
Estyle (2020), Golding Farms Foods (2017), Lakeshirts / Blue 84 (2019), and recteq (2021) [S2].
Industrial
Quantum Design International (2024), Stratton Aviation (2026), and Tooling Technology Group (2017) [S2].
Other
Captain D’s in consumer/restaurant (2022), Jitterbit in technology (2023), and Keany Produce & Gourmet in distribution (2022) [S2].
Recent activity (last 24 months)
* Stratton Aviation acquisition (May 2026) [S1]
* Western Botanicals acquisition (February 2026) [S1]
* Velocity Rail Solutions and Liquid Tech Solutions acquisition (July 2025) [S1]
* Liquid Tech Solutions (2025) [S2]
* Quantum Design International (2024) [S2]
* Market Performance Group (2024) [S2]
* ConvenientMD (2024) [S2]
* Behavioral Innovations (2024) [S2]
How this firm fits a seller
Yukon Partners appears to pursue platform investments across multiple sectors rather than specializing in a single vertical, based on its publicly disclosed portfolio composition [S2]. The firm has demonstrated repeat investment activity in healthcare services, completing at least four acquisitions in that sector during 2024 alone [S2]. For owner-operators in healthcare, business services, consumer products, or industrial sectors, the firm’s transaction history suggests active buying appetite as of mid-2026 [S1][S2]. The portfolio includes both founder-led businesses and established brands, indicating potential flexibility in deal structure and management transition.
Sources
[S1] https://yukonpartners.com/news/ (as of 2026-01-15)
[S2] https://yukonpartners.com/portfolio/ (as of 2025-01-15)
Frequently asked questions
Does Yukon Partners buy Healthcare Services businesses?
Yes, healthcare services represents the most active sector in Yukon Partners’ portfolio, with approximately nine companies in the space as of early 2025 [S2]. Recent healthcare acquisitions include Behavioral Innovations and ConvenientMD, both completed in 2024 [S2].
What companies has Yukon Partners acquired recently?
Recent acquisitions include Stratton Aviation (May 2026), Western Botanicals (February 2026), and Velocity Rail Solutions combined with Liquid Tech Solutions (July 2025), per the firm’s news page [S1]. In 2024, the firm acquired Behavioral Innovations, ConvenientMD, Market Performance Group, and Quantum Design International [S2].
Where is Yukon Partners based and how big is the firm?
Yukon Partners is headquartered in Minneapolis, MN, according to its website [S1]. Fund size and assets under management were not publicly disclosed in available sources as of early 2026.
Is Yukon Partners still actively acquiring?
Yes, Yukon Partners completed its most recent publicly disclosed acquisition in May 2026 with Stratton Aviation [S1]. The firm has announced at least eight transactions since the beginning of 2024, indicating ongoing active investment activity [S1][S2].
This profile is maintained by CT Acquisitions as an independent third-party reference. CT Acquisitions is not affiliated with, endorsed by, or a representative of the firm profiled. All facts sourced from publicly available materials as of the dates cited.